Lilly Sees 2022 Profit Above Estimates on Boost From Potential New Drugs

Eli Lilly on Wednesday forecast 2022 profit above Wall Street estimates, as it bets on new drug approvals to counter the impact of competition and pricing pressures on its other key treatments. Read More